cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Verastem Inc
19 own
45 watching
Current Price
$3.32
$0.03
(0.91%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
0
52-Week High
52-Week High
14.22000
52-Week Low
52-Week Low
2.60000
Average Volume
Average Volume
0.23M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization0
icon52-Week High14.22000
icon52-Week Low2.60000
iconAverage Volume0.23M
iconDividend Yield--
iconP/E Ratio--
What does the Verastem Inc do?
Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing drugs targeting cancer stem cells (CSCs). Its programs target the focal adhesion kinase (FAK) and the PI3K/mTOR signaling pathways. The company's product candidate FAK inhibitor, VS-6063, is in Phase 1 study in combination with PD-1 inhibitor pembrolizumab and gemcitabine for pancreatic cancer; a Phase Ib clinical trial in combination with paclitaxel for patients with ovarian cancer; a Phase II study in patients with non-small cell lung cancer; a Phase II trial preceding surgery in mesothelioma; and a Phase 1/1b clinical trail in combination with avelumab in patients with ovarian cancer, as well as a combination trial of VS-6063 and VS-5584 in patients with relapsed mesothelioma. It is also developing FAK inhibitor, VS-4718 that is in Phase 1, single-agent, dose escalation trial in patients with advanced cancers; and a Phase 1, dose-escalation clinical trial in combination with gemcitabine and nab-paclitaxel in patients with advanced solid tumors, as well as a Phase 1, dose-escalation clinical trial of PI3K/mTORC1/2 inhibitor, VS-5584, in patients with advanced non-hematologic malignancies or lymphoma. The company has license agreement with Whitehead Institute for Biomedical Research; The Scripps Research Institute; and Pfizer, Inc. Verastem, Inc. was founded in 2010 and is based in Needham, Massachusetts.
Read More
How much money does Verastem Inc make?
News & Events about Verastem Inc.
Business Wire
1 year ago
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 7,181,409 shares of its common stock at a price to the public of $9.75 per share and, in lieu of common...
PR Newswire
1 year ago
Thinking about buying stock in Panbela Therapeutics, Verastem, Nio, Enphase Energy, or FingerMotion? Thinking about buying stock in Panbela Therapeutics, Verastem, Nio, Enphase Energy, or FingerMotion? PR Newswire NEW YORK, June 16, 2023 NEW YORK, June 16, 2023 /PRNewswire/ -- InvestorsObserver...
PR Newswire
1 year ago
Thinking about trading options or stock in Inpixon, DatChat, Esperion Therapeutics, Verastem, or Vision Marine Technologies? Thinking about trading options or stock in Inpixon, DatChat, Esperion Therapeutics, Verastem, or Vision Marine Technologies? PR Newswire NEW YORK, June 15, 2023 NEW YORK...
Zolmax
1 year ago
StockNews.com initiated coverage on shares of Verastem (NASDAQ:VSTM Get Rating) in a report published on Wednesday. The brokerage issued a hold rating on the biopharmaceutical companys stock. A number of other research analysts have also recently weighed in on the stock. HC Wainwright reiterated a ...
Ticker Report
1 year ago
Royal Bank of Canada reaffirmed their outperform rating on shares of Verastem (NASDAQ:VSTM Get Rating) in a research report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has a $3.00 price objective on the biopharmaceutical companys stock. Several ...
Frequently Asked Questions
Frequently Asked Questions
What is Verastem Inc share price today?
plus_minus_icon
Can Indians buy Verastem Inc shares?
plus_minus_icon
How can I buy Verastem Inc shares from India?
plus_minus_icon
Can Fractional shares of Verastem Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Verastem Inc stocks?
plus_minus_icon
What is today’s traded volume of Verastem Inc?
plus_minus_icon
What is today’s market capitalisation of Verastem Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Verastem Inc?
plus_minus_icon
What percentage is Verastem Inc down from its 52-Week High?
plus_minus_icon
What percentage is Verastem Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.32
$0.03
(0.91%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00